For reasons that are not completely understood, remyelination is often incomplete, producing thin myelin sheaths with disorganized structure. We investigated the cellular basis for this altered myelin structure, and found that the response of oligodendrocyte progenitor cells (OPCs), and mature oligodendrocytes to TNFα and IL-1β is modified by the expression of the sphingomyelin hydrolase nSMase2. OPCs do not express nSMase2, and exhibit a protective response to these cytokines manifest by decreased ceramide, increased sphingosine 1-phosphate, and increased cell motility. Mature oligodendrocytes express nSMase2, and respond to TNFα and IL-1β with a stress phenotype, evidenced by increased ceramide, decreased sphingosine, and active caspase 3. Pharmacological inhibition or a targeted genetic deletion of nSMase2 in vivo increased myelin thickness, and enhanced myelin compaction. These results suggest that inhibition of nSMase2 improves the quality of new myelin by protecting maturing/myelinating oligodendrocytes. Pharmacological inhibition of nSMase2 following a demyelinating event could stabilize the structure of these newly formed myelin sheaths and protect them from secondary demyelination.
Introduction
A highly synchronized and complex generation of multiple classes of lipid and select proteins regulates the biophysical properties of myelination. The lipid composition of myelin is asymmetrically distributed to allow for membrane curvature and myelin compaction.
Intramembrane adhesions are critical for myelin to maintain its compact structure. The head to head arrangement of lipids in myelin creates a repulsive energy between opposing layers that is overcome at the major dense line by the stabilizing actions of myelin basic protein (MBP).
Genetic deletion of nSMase2 in remyelinating oligodendrocytes stabilized sphingolipid composition and promoted remyelination
To conditionally delete smpd3 specifically in a cell-type specific manner, floxed smpd3 mice (smpd3 fl/fl ) were crossed with PDGFRα-CreER mice ( Fig 6A) to selectively delete the nSMase2 gene in remyelinating oligodendrocytes. PDGFRα-CreER; smpd3 fl/fl mice were fed a cuprizone containing diet for 4 weeks, then were administered tamoxifen (1 mg, I.P.) during the first 5 days of return to a normal diet (4 weeks). Mice were sacrificed 4 weeks after return to a regular diet ( Fig 6B) . Tamoxifen-induced deletion of nSMase2 in remyelinating axons in the PDGFRα-CreER; smpd3 fl/fl mice was validated by immunohistochemical analysis of pCC ( Fig 6C) .
PDGFRα-CreER; smpd3 fl/fl mice fed a cuprizone containing diet showed extensive loss of MBP+ myelin in the pCC compared to the mice fed a standard diet. Additionally, expression of nSMase2 was diminished along with loss of MBP in pCC, indicating that nSMase2 was enriched in MBP+ oligodendrocytes. Following return to a standard diet MBP+ myelin largely recovered in pCC, and was enriched with nSMase2+ cells. Mice in which nSMase2 was deleted by administration of tamoxifen during remyelination (CPZ-ND-Tam) exhibited complete loss of nSMase2 and almost complete recovery of MBP+ myelin in the pCC, indicating that inhibition of nSMase2 promoted remyelination. We next analyzed sphingolipid contents in these mice to confirm if deletion of nSMase2 stabilized sphingolipid perturbations during remyelination ( Figure 6C ). Similar to the results from wild-type mice exposed to CPZ followed by remyelination, PDGFRα-CreER; smpd3 fl/fl mice subjected to remyelination following CPZ exhibited elevation of multiple ceramides in pCC compared to control mice on a normal diet (C16:0, 20:0, 22:0, 24:0). However, mice administered tamoxifen during remyelination (CPZ-ND-Tam) had lower elevations of these multiple ceramides in pCC compared to 20:0, 22:0, 24:0, 22:1, 24:1) . Several monohexosyl ceramides (C24:0, 22:1, 24:1) and lactosyl ceramides (C22:0, C24:1) in pCC of mice subjected to remyelination (CPZ+ND) were different from levels in pCC of control mice, and deletion of nSMase2 significantly lowered their levels during remyelination. Overall levels of sphingomyelins were not significantly altered in mice where nSMase2 was deleted during remyelination. Moreover, the sustained overall decrease of multiple sulfatides in pCC of the mice observed during remyelination was not affected by deletion of nSMase2 during remyelination. Only one species of sulfatide (C18:0) was recovered by deletion of nSMase2 during remyelination. Genomic deletion of nSMase2 in remyelinating oligodendrocytes resulted in an overall decrease of most of ceramides in other brain regions of PDGFRα-CreER; smpd3 fl/fl mice compared to the mice with functional nSMase2 (Supplementary Figure 3) . These data suggest that genomic deletion of nSMase2 from remyelinating oligodendrocytes stabilized sphingolipid metabolism during remyelination.
Next, we analyzed ultrastructure of myelin around axons from mice with deleted nSMase2.
While the axons in pCC of PDGFRα-CreER; smpd3 fl/fl mice subjected to remyelination following demyelination (CPZ-ND) were less-myelinated with thinner myelin than mice on normal diet, the axons in nSMase2 deleted mice (CPZ-ND+Tam) were almost completely remyelinated (28.0 ± 10.6% increase over Tam-) and sheaths were similar in thickness to control mice (6.6 ± 5.8% increase than Tam-; Figure 6E -G). These results suggest that nSMase2 expression by remyelinating oligodendrocytes is detrimental for proper remyelination in CPZinduced demyelination/ remyelination, and that normalizing sphingolipid perturbations by deletion of nSMase2 can enhance remyelination.
Discussion
Following a demyelinating event, OPCs are recruited to the lesion site where they differentiate into myelinating oligodendrocytes. Myelination requires that oligodendrocyte processes wrap axons and ultimately compact to stabilize the myelin sheath and underling axon. The process of myelination involves a highly synchronized production of multiple types of lipids that regulate membrane curvature and compaction. Here we provide evidence that this orchestrated synthesis of lipids is perturbed during remyelination through mechanisms that involve the sphingomyelin hydrolase nSMase2. OPCs do not express nSMase2 and exhibit a protective/instructional response to TNFα and IL-1β. As OPCs differentiate into MBP+ myelinating oligodendrocytes they express nSMase2 and exhibit an injury response to TNFα and IL-1β. Inhibition of nSMase2 during remyelination in the cuprizone model of demyelination/remyelination restores the ceramide content of myelin to baseline levels, increases the number of remyelinated axons and the thickness of myelin.
The cuprizone diet rodent model of demyelination and remyelination is characterized by a global degeneration of myelin largely in the corpus callosum, with some involvement of cortical and subcortical regions (Matsushima & Morell, 2001) . Although the precise mechanism(s) of oligodendrocyte susceptibility to cuprizone remain unclear, and it is not considered a model involving a fulminant immune activation, there is considerable evidence for an immune component to cuprizone-induced demyelination and remyelination. The chemoattractant responsive C-X-C chemokine receptor type 2 on neutrophils is involved in cuprizone-induced demyelination, and inhibition of CXCR2 results in better myelin repair, presumably by allowing optimal spatiotemporal positioning of OPCs in demyelinating lesions (Liu, Darnall et al., 2010) .
The activation of astrocytes and microglia is readily apparent in the cuprizone model, and appears to involve the Toll-like receptor 2 (Esser, Gopfrich et al., 2018) . Glial activation is part of the innate immune response, and is critical for remyelination. Activated astrocytes produce the chemoattractant CXCL10 that recruits microglia to phagocytosis cellular debris during demyelination and remyelination. This clearance activity, in conjunction with the increased production of TNF-α, IGF-1, and FGF-2 creates a microenvironment that supports regeneration (Skripuletz, Hackstette et al., 2013 , Voss, Skuljec et al., 2012 . Ablation of astrocytes in a GFAP-thymidine kinase transgenic mouse model was associated with a failure to clear myelin debris and deficits in remyelination (Skripuletz et al., 2013) . Genetic ablation of CXCR3 (receptor for CXCL10 and CXCL9) likewise resulted in deficits of glial activation, debris clearance and remyelination (Krauthausen, Saxe et al., 2014) . Similar results were observed in IL-1β-deficient mice that failed to remyelinate properly, and showed a profound delay of OPCs to differentiate into mature oligodendrocytes (Mason, Suzuki et al., 2001) . These data suggest that inhibiting the early neuroinflammatory response is detrimental to remyelination.
While the inflammatory response is beneficial and necessary for tissue repair following damage, prolonged inflammation can be detrimental to tissue repair (Reviewed in(Le Thuc, Blondeau et al., 2015) ). Our data suggest that the developmental expression of nSMase2 may be one mechanistic explanation for this dual effect of inflammation. OPCs do not express nSMase2, and when exposed to TNFα or IL-1β show reduced levels of active caspase3, increased motility, reductions in ceramide, and increases in S1P, each indicative of a protective response. During differentiation, maturing oligodendrocytes express nSMase2, and this expression dramatically changes the cellular response to inflammatory cytokines. Mature oligodendrocytes exposed to TNFα show increased levels of active caspase3, and increased ceramide, indicating a toxic response to this inflammatory cytokine. TNF and IL1 receptors are physically associated with nSMase2 through the WD-repeat protein Fan (Factor associated with nSMase activation) and may form a complex with other modulators including EED (embryonic ectodermal development), and RACK1 (Receptor of activated protein C kinase 1) (Adam-Klages et al., 1996 , Taupin, 2010 , Tcherkasowa, Adam-Klages et al., 2002 . Expressing nSMase2 in OPCs, and genetic deletion of nSMase2 in mature oligodendrocytes confirmed that this differential response to TNFα was due to the expression (or lack of expression) of nSMase2. Thus, expression of nSMase2 during transition of OPCs to oligodendrocytes provides a promising therapeutic target, which does not modify the early protective response of OPCs to inflammatory cytokines, but could protect maturing oligodendrocytes during remyelination.
Myelin has a very high lipid to protein content with the lipid components representing ~80% of the total dry weight (O'Brien & Sampson, 1965 , Rouser, Galli et al., 1965 . Maintaining the correct lipid composition of myelin is essential for myelin structure and function. The lipid content of CSF and normal appearing white matter in MS brain tissues is modified with a higher phospholipid and ceramide content, increased lipid peroxidation, and a total sulfatide content that is reduced by 25% (Takahashi & Suzuki, 2012 , Vidaurre, Haines et al., 2014 , Wheeler et al., 2008 . Remyelinated axons in the cuprizone model recapitulate some of these modifications in lipid content. We found that remyelination was incomplete and many of the remyelinated axons in the posterior corpus callosum were thinly myelinated, or the myelin was disorganized and not compacted, similar to findings by other groups (Guo, Suo et al., 2018 , Mullin, Cui et al., 2017 , Tagge, O'Connor et al., 2016 . This disorganization was accompanied by an abnormal lipid content with increased ceramide, increased sphingomyelin, reduced hexosylceramide and sulfatide. Pharmacological inhibition or a targeted knock-out of nSMase2 in newly generated oligodendrocytes corrected the ceramide content of remyelinated axons in the posterior corpus callosum, increased the myelin thickness, and dramatically reduced the number of axons with disorganized/uncompacted myelin. However, inhibition of nSMase2 did not normalize the reduced level of GalCer or sulfatide content of remyelinated axons.
GalCer, and sulfatide account for ~20% and 5% respectively of myelin lipid content (Boggs, Gao et al., 2008 , Marcus, Honigbaum et al., 2006 . The synthesis of these galactosphingolipids involves the addition of galactose from UDP-galactose to ceramide in a reaction catalyzed by ceramide galactosyltransferase, and the subsequent addition of a sulfate group by cerebroside sulfotransferase (CST) (Honke, 2013). The synthesis of GalCer and sulfatide occurs in mature myelinating oligodendrocytes, and marks the transition from late OPCs to immature oligodendrocytes (Poduslo & Miller, 1985 , Raff, Mirsky et al., 1978 . Both GalCer and sulfatide form phase separated domains in model membranes, and are strongly associated with ceramide and cholesterol in lipid raft domains (Hao, Sun et al., 2009) . The importance of these lipids in myelin stability was demonstrated in CGT-/-knock out mice that do not make GalCer or sulfatide. CNS myelin in these mice is thinner, nodal long is increased and lateral loops are widely spaced, with extensive vacuolization between the sheaths and axolemma (Bosio, Binczek et al., 1998 , Dupree, Coetzee et al., 1998 . CGT-/-mice typically die within three months of age (Dupree et al., 1998) . CST-/-knockout mice are unable to synthesize sulfatide, but the level of other glycolipids including GalCer normal. These mice are born healthy and produce compact myelin (albeit thinner myelin), but display progressive myelin abnormalities including a reduction in total myelin lipid content (due to a reduction in lipid synthesis by oligodendrocytes), nodal structure deterioration, myelin vacuolar degeneration, and reductions of axon caliber, with abnormal clustering of Na 2+ and K + channels (Ishibashi, Dupree et al., 2002 , Marcus et al., 2006 , Palavicini, Wang et al., 2016 . These findings, in consideration of our current results showing reduction of GalCer and sulfatide in remyelinated axons, suggests there may be a deficiency in CST activity during remyelination.
Our findings indicate that developmental expression of nSMase2 modifies the cellular response to inflammation, from being protective at the OPC stage, to damaging in myelinating oligodendrocyte stage. Pharmacological inhibition or genetic deletion of nSMase2 did not modify the instructive or protective response of OPCs to inflammatory stimuli, but protected myelinating oligodendrocytes. This targeted protection of maturing oligodendrocytes partially restored myelin lipid composition, and improved the biophysical properties of myelin to allow greater compaction, suggesting that targeted modification of this pathway within premyelinating oligodedendrocytes could be beneficial in promoting myelin repair in MS.
Materials and Methods

Animals and induction of demyelination / remyelination
Pregnant female Sprague-Dawley (SD) rats (embryonic day 17), and male C57BL6 mice (8-10 weeks old) were obtained from the Jackson Laboratory (Bar Harbor, ME). Mice were housed in a temperature and humidity-controlled room under a 12h light cycle. Mice were allowed to acclimate to the colony room for at least 7 days after arrival before experimentation. All procedures were conducted in accordance with NIH guidelines for the Use of Animals and Humans in Neuroscience Research and approved by Institutional Animal Care and Use Committee (Johns Hopkins University School of Medicine). To induce demyelination, mice were fed 0.2% (w/w) cuprizone (bis(cyclo-hexanone) oxaldihydrazone (Sigma) mixed with a powdered rodent diet containing18% protein (Teklad Global) for 4 weeks. Mice were then returned to a normal diet (ND) for 4-6 weeks to promote remeylination (173 mice total; 52 mice for ND, 121 mice for cuprizone diet followed by direct sacrifice, ND, or ND with drug infusion.
Mice were identified by earmarks and numbered accordingly, randomly grouped before starting demyelination or remyelination. During experiments and analysis, the investigators were blinded to experimental group.
In vivo inhibition of nSMase2 was accomplished by a mini-osmotic pump (Alzet, Cupertino, . Two to three months old mice (males and females) were exposed to cuprizone feeding for 4 weeks to induce demyelination and recovered for 4 weeks with normal diet (34 mice total; 9 mice for ND, 25 mice for cuprizone followed by direct sacrifice, ND, or ND+tamoxifen). For the first 5 days of remyelination the mice were administered 4-hydroxytamoxifen (4-HT, 1mg/day/mouse, Sigma) as previously described (Baxi, DeBruin et al., 2015) , to delete smpd3. The mice were sacrificed after 4 weeks of remyelination, and the brains were rapidly extracted and stored at -80°C for analysis.
Histology and Electron Microscopy
Mice were transcardially perfused with 0.9% NaCl followed by 4% PFA, and the brains were post-fixed with 4% PFA for overnight at 4°C. Black Gold staining was conducted according to the manufacturer's instructions (Black Gold II myelin staining kit, EMD Millipore, Billerica, MA). Briefly, 30μm thick brain sections were incubated with 0.3% Black Gold at 60°C for 20min. Sections were then fixed with 1% sodium thiosulfate for 3min, dehydrated using a series of gradated alcohols, cleared in xylene, and cover-slipped with mounting medium (EMD Millipore, Billerica, MA). Myelination of axons in pCC was calculated as the percent area stained with Black Gold in total pCC from 3 sequential sections (180 µm apart).
For electron microscopy (EM) mice were anesthetized with isofluorane and perfused transcardially with 4% PFA, 0.1% glutaraldehyde, in 0.1M sodium phosphate buffer (pH 7.4).
Brains were post fixed with 4% PFA, 2%glutaraldehyde, 2.5% sucrose, and 3 mM NaCl in 0.1M sodium cacodylate buffer (pH 7.4). Fixed tissues were dissected, dehydrated in graded ethanol, embedded in EMBed-812 resin (Electron Microscopy Sciences, Hatfield, PA). Thin sections (90nm) were cut with a diamond knife using a Reichert-Jung Ultracut E ultramicrotome and picked up with copper slot (1 X 2 mm) grids. Grids were stained with 2% uranyl acetate and lead citrate then viewed using Zeiss Libra 120 transmission electron microscope with a Veleta camera (Olympus, Muenster, Germany). G-ratios were calculated as the % of axonal myelination by measuring the inner and outer diameter of myelinated axons (Baxi et al., 2015) . Ten images selected from the central posterior corpus callosum were quantified per mouse (~20-50 axons/ image). 
Measurement of nSMase2 activity
Fig. 4. Inhibition of nSMase2 blocked cuprizone-induced demyelination.
A Schematic illustration showing the timing of cambinol infusion during cuprizone (CPZ)induced demyelination. Cambinol was unilaterally infused into lateral ventricle 2 days prior to cuprizone feeding (CPZ) for 28 days at the rate of 0.31 µg/kg/day. B Quantitation of nSMase2 activity in the cortex of mice exposed to CPZ following vehicle or cambinol infusion showing that cambinol blocked CPZ-induced nSMase2 activity (n=5 in each group). C Representative images of MBP (green) and nSMase2 (red) fluorescence in the pCC of mice fed a normal diet (ND), a cuprizone containing diet (CPZ) for 4-weeks, a CPZ diet and return to ND for 4 weeks (CPZ+Re), and CPZ with tamoxifen induction of nSMase2 deletion during the first 5 days of return to ND (CPZ+ND+Tam). Increased expression of nSMase2 in the CPZ+ND group is absent in the CPZ+ND+Tam group, and myelin basic protein (MBP) staining is more robust in the CPZ+ND+Tam group compared to the CPZ+ND group. Scale bar = 100 μM. 
